SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-041515
Filing Date
2021-03-25
Accepted
2021-03-25 16:16:00
Documents
88
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm211090d1_10k.htm 10-K 1068535
2 EXHIBIT 10.22 tm211090d1_ex10-22.htm EX-10.22 190587
3 EXHIBIT 10.23 tm211090d1_ex10-23.htm EX-10.23 181422
4 EXHIBIT 21.1 tm211090d1_ex21-1.htm EX-21.1 2190
5 EXHIBIT 23.1 tm211090d1_ex23-1.htm EX-23.1 4170
6 EXHIBIT 31.1 tm211090d1_ex31-1.htm EX-31.1 10957
7 EXHIBIT 31.2 tm211090d1_ex31-2.htm EX-31.2 10965
8 EXHIBIT 32.1 tm211090d1_ex32-1.htm EX-32.1 5291
9 EXHIBIT 32.2 tm211090d1_ex32-2.htm EX-32.2 4947
16 GRAPHIC tm211090d1001.jpg GRAPHIC 134200
17 GRAPHIC tm211090d1002.jpg GRAPHIC 10086
18 GRAPHIC tm211090d1003.jpg GRAPHIC 11085
19 GRAPHIC tm211090d1004.jpg GRAPHIC 18008
20 GRAPHIC tm211090d1005.jpg GRAPHIC 15937
21 GRAPHIC tm211090d1006.jpg GRAPHIC 24587
22 GRAPHIC tm211090d1007.jpg GRAPHIC 27943
  Complete submission text file 0001104659-21-041515.txt   6991909

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT eyeg-20201231.xml EX-101.INS 1357584
11 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20201231.xsd EX-101.SCH 53605
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20201231_cal.xml EX-101.CAL 67255
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20201231_def.xml EX-101.DEF 200170
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20201231_lab.xml EX-101.LAB 456147
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20201231_pre.xml EX-101.PRE 387440
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36672 | Film No.: 21772563
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences